Balaji Amines Limited (NSE:BALAMINES)

Market Cap	43.61B
Revenue (ttm)	14.58B
Net Income (ttm)	1.85B
Shares Out	n/a
EPS (ttm)	57.24
PE Ratio	23.51
Forward PE	18.21
Dividend	11.00 (0.84%)
Ex-Dividend Date	Jul 4, 2024

Volume	63,367
Average Volume	54,318
Open	1,344.00
Previous Close	1,347.20
Day's Range	1,343.90 - 1,390.00
52-Week Range	1,127.55 - 2,549.75
Beta	0.63
RSI	62.09
Earnings Date	May 8, 2025

About Balaji Amines

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1988
• Employees: 1,084
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BALAMINES

Financial Performance

In 2023, Balaji Amines's revenue was 16.42 billion, a decrease of -30.31% compared to the previous year's 23.55 billion. Earnings were 2.05 billion, a decrease of -37.07%.